Abstract:Abstract Background Interleukin-33 (IL-33) is an effective inducer of pro-inflammatory cytokines regulating innate and adaptive immunity. Inflammation could be a double-edged sword, promoting or inhibiting tumour growth. To date, the roles and mechanisms of IL-33 in tumours remain controversial. Here, we examined the effect of exogenous IL-33 on the biological characteristics of hepatocellular carcinoma (HCC) and the possible mechanism of action. Methods In this study, IL-33 expression in the tissues of 69 HCC patients was detected and its relationship with prognosis was evaluated. After establishing a mouse HCC model and IL-33 treatment operation, the infiltration of splenic myeloid-derived suppressor (MDSCs), dendritic (DCs), regulatory T, and natural killer (NK) cells was detected by flow cytometry analysis, and the vascular density of the tumour tissues was detected by immunohistochemistry to reveal the mechanism of IL-33 in HCC proliferation. Finally, the Cancer Genome Atlas database was used to analyse Gene Ontology terms the and Kyoto Encyclopaedia of Genes and Genomes pathway. Moreover, the chi-square test, two-tailed unpaired Student’s t -test, and multiple t- tests were performed using SPSS version 23.0 and GraphPad Prism 8.0 software. Results The IL-33 expression level was negatively correlated with the overall survival of HCC patients, suggesting its potential clinical significance in the prognosis of HCC. We found that systemic IL-33 administration significantly promoted the tumour size in vivo. Furthermore, the IL-33-treated mice presented decreased frequencies of tumouricidal NK and CD69 + CD8 + T cells. After IL-33 treatment, the incidence of monocytic MDSCs and conventional DCs increased, while that of granulocytic MDSCs decreased. Moreover, IL-33 promoted the formation of intracellular neovascularization. Therefore, IL-33 accelerated HCC progression by increasing the accumulation of immunosuppressive cells and neovascularization formation. Finally, we found that the transcription of IL-33 was closely related to the PI3K-Akt and MAPK pathways in Gene Set Enrichment Analysis plots, which were involved in the tumourigenesis and pathogenesis of HCC. Conclusions Taken together, IL-33 may be a key tumour promoter of HCC proliferation and tumourigenicity, an important mediator, and a potential therapeutic target for regulating HCC progression.

Hyperactivity of the IL-33-ILC2s-IL-13-M-MDSCs Axis Promotes Cervical Cancer Progression

Interleukin 33 in Tumor Microenvironment is Crucial for the Accumulation and Function of Myeloid-Derived Suppressor Cells

The combined action of monocytic myeloid-derived suppressor cells and mucosal-associated invariant T cells promotes the progression of cervical cancer

Increased Circulating GrMyeloid-derived Suppressor Cells Correlated with Tumor Burden and Survival in Locally Advanced Cervical Cancer Patient

Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy

Relationship and prognostic significance of IL‐33, PD‐1/PD‐L1, and tertiary lymphoid structures in cervical cancer

Oct4 activates IL-17A to orchestrate M2 macrophage polarization and cervical cancer metastasis

Myeloid-derived suppressor cells cross-talk with B10 cells by BAFF/BAFF-R pathway to promote immunosuppression in cervical cancer

Negative immune factors might predominate local tumor immune status and promote carcinogenesis in cervical carcinoma

IL-32/NFκB/miR-205 loop sustains the high expression of IL-32 and enhances the motility of cervical cancer cells

Elevated Expression of Programmed Death-1 and Programmed Death Ligand-1 Negatively Regulates Immune Response Against Cervical Cancer Cells

Interactions of Indoleamine 2,3‐dioxygenase‐expressing LAMP3+ Dendritic Cells with CD4+ Regulatory T Cells and CD8+ Exhausted T Cells: Synergistically Remodeling of the Immunosuppressive Microenvironment in Cervical Cancer and Therapeutic Implications

Tumor-Derived IL33 Promotes Tissue-Resident CD8+ T Cells and Is Required for Checkpoint Blockade Tumor Immunotherapy.

Aberrant Expressions of Immune Factors Facilitate the Disequilibrium of Immune Status in Cervical Cancer

Exogenous interleukin-33 promotes hepatocellular carcinoma growth by remodelling the tumour microenvironment

CXCL2/MIF-CXCR2 Signaling Promotes the Recruitment of Myeloid-Derived Suppressor Cells and is Correlated with Prognosis in Bladder Cancer

Exogenous IL-33 promotes tumor immunity via macroscopic regulation of ILC2s

Examining IL-33 Expression in the Cervix of HPV-infected Patients: a Preliminary Study Comparing IL-33 Levels in Different Stages of Disease and Analyzing Its Potential Association with IFN-γ

The investigation of regulatory role of immune factors FoxP3,CCL22 and CCR4 in the mi-croenvironment of cervical cancer

IL-33 Drives the Antitumour Effects of Dendritic Cells Via Upregulating CYLD Expression in Pulmonary Adenocarcinoma.

Elevation of blood Th17 cells and CD3~+CD8~-IL-21~+ T cells in patients with cervical cancer